ALNYLAM PHARMACEUTICALS, INC.
CIK 1178670 · last filed 2016-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
20
Lifetime Open-Market Net
-$11.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 4,896,716 | $8.16 | $39.96M | -$11.28M | 20 | 2016-02-24 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-08-29 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −5,000 | -$35.0K | EDGAR |
| 2014-08-22 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,750 | -$74.1K | EDGAR |
| 2014-08-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −5,450 | -$38.2K | EDGAR |
| 2014-08-08 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −7,600 | -$52.2K | EDGAR |
| 2014-08-01 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −5,350 | -$34.0K | EDGAR |
| 2014-07-25 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −5,250 | -$35.4K | EDGAR |
| 2014-07-18 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −13,500 | -$90.0K | EDGAR |
| 2014-07-11 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −8,050 | -$54.2K | EDGAR |
| 2014-07-07 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −4,300 | -$34.7K | EDGAR |
| 2012-10-11 | Regulus Therapeutics Inc. (RGLS) Delisted | Conv (C) | +6,150,500 | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.